The introduction of thalidomide, lenalidomide, and bortezomib has changed the way that multiple myeloma (MM) is treated and has greatly improved survival outcomes. These novel agents are often used in combination with conventional drugs, such as dexamethasone, to optimize clinical responses; however
β¦ LIBER β¦
Novel Therapies in Multiple Myeloma
β Scribed by Seema Singhal; Jayesh Mehta
- Publisher
- Carden Jennings Publishing
- Year
- 2003
- Tongue
- English
- Weight
- 183 KB
- Volume
- 77
- Category
- Article
- ISSN
- 0925-5710
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Future drug developments in multiple mye
β
Gareth Morgan
π
Article
π
2010
π
Elsevier Science
π
English
β 214 KB
Novel biologically based therapies for m
β
Nikhil C. Munshi; Teru Hideshima; Dharminder Chauhan; Paul Richardson; Kenneth C
π
Article
π
2002
π
Carden Jennings Publishing
π
English
β 323 KB
New therapies in multiple myeloma
β
F. Merchionne; F. Perosa; F. Dammacco
π
Article
π
2007
π
Springer
π
English
β 157 KB
Circulating angiopoietin-1 to angiopoiet
β
Evangelos Terpos; Konstantinos Anargyrou; Eirini Katodritou; Efstathios Kastriti
π
Article
π
2011
π
John Wiley and Sons
π
French
β 456 KB
π 1 views
## Abstract The circulating levels of several angiogenic cytokines [angiopoietinβ1 (Angβ1), angiopoietinβ2 (Angβ2), vascular endothelial growth factor (VEGF), angiogenin and basic fibroblast growth factor (bFGF)] were evaluated in 174 consecutive patients with newly diagnosed, symptomatic, multiple
Therapy of multiple myeloma
β
Goldschmidt H.; Cremer F. W.; MΓΆhler Th.; KrΓ€mer A.; GΓΆrner M.; Egerer G.; Ho A.
π
Article
π
2002
π
Springer
π
English
β 359 KB
Combination therapy for multiple myeloma
β
Dr. Raymond Alexanian; Sydney Salmon; John Bonnet; Edmund Gehan; Arthur Haut; Ja
π
Article
π
1977
π
John Wiley and Sons
π
English
β 588 KB